Procept Biorobotics Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Procept Biorobotics Corp 公司

PROCEPT BioRobotics Corporation 是一家商业阶段的手术机器人公司。该公司致力于通过开发泌尿外科的变革性解决方案来推进患者护理。该公司开发、制造和销售 AQUABEAM 机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初专注于治疗良性前列腺增生 (BPH)。该公司专有的 AQUABEAM 机器人系统提供水消融疗法，该疗法结合了实时、多维成像、个性化治疗计划、自动化机器人和无热水射流消融，可有针对性地快速去除前列腺组织。水消融疗法可为因 BPH 而患有下尿路症状 (LUTS) 的男性提供有效、安全和持久的治疗效果，且与前列腺的大小和形状或外科医生的经验无关。

公司简介

公司代码PRCT

公司名称Procept Biorobotics Corp

上市日期Sep 15, 2021

成立日期2021

CEODr. Reza Zadno, Ph.D.

员工数量756

证券类型Ordinary Share

年结日Sep 15

公司地址150 Baytech Drive

城市SAN JOSE

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编95134

电话16502329832

网址https://www.procept-biorobotics.com/

公司代码PRCT

上市日期Sep 15, 2021

成立日期2021

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

843.16K

+0.18%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Dr. Reza Zadno, Ph.D.

President, Chief Executive Officer, Director

65.97K

+26.35%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

Ms. Elisabeth Little

Independent Director

11.02K

--

Mr. Larry L. Wood

Independent Director

5.97K

+34.72%

Thomas M. Prescott

Independent Chairman of the Board

3.90K

+65.22%

Ms. Alaleh Azarkhish Nouri

Executive Vice President, Chief Legal Officer, Corporate Secretary

--

名称

名称/职务

职务

持股

持股变动

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

843.16K

+0.18%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Dr. Reza Zadno, Ph.D.

President, Chief Executive Officer, Director

65.97K

+26.35%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

地区USD

名称

营收

占比

United States

60.29M

87.18%

Outside United States

8.87M

12.82%

业务

地区

业务USD

名称

营收

占比

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

股东统计

更新时间: 6月8日周日

持股股东

股东类型

持股股东

占比

Fidelity Management & Research Company LLC

14.67%

The Vanguard Group, Inc.

9.25%

BlackRock Institutional Trust Company, N.A.

6.24%

AllianceBernstein L.P.

3.87%

T. Rowe Price Investment Management, Inc.

2.56%

Other

63.41%

持股股东

占比

Fidelity Management & Research Company LLC

14.67%

The Vanguard Group, Inc.

9.25%

BlackRock Institutional Trust Company, N.A.

6.24%

AllianceBernstein L.P.

3.87%

T. Rowe Price Investment Management, Inc.

2.56%

Other

63.41%

股东类型

持股股东

占比

Investment Advisor

45.36%

Investment Advisor/Hedge Fund

34.67%

Hedge Fund

7.57%

Individual Investor

4.25%

Research Firm

3.31%

Bank and Trust

1.10%

Pension Fund

0.73%

Venture Capital

0.66%

Family Office

0.08%

Other

2.26%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

528

53.99M

97.59%

-2.22M

2025Q1

539

53.99M

97.68%

-2.82M

2024Q4

499

53.70M

99.42%

+875.53K

2024Q3

449

49.13M

94.16%

-1.41M

2024Q2

393

47.17M

91.61%

-2.29M

2024Q1

345

48.36M

95.04%

-4.45M

2023Q4

326

47.80M

94.81%

-4.63M

2023Q3

322

46.77M

93.30%

+2.15M

2023Q2

298

38.23M

84.44%

-1.74M

2023Q1

275

35.37M

78.88%

-3.41M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Fidelity Management & Research Company LLC

8.12M

14.67%

+55.63K

+0.69%

Mar 31, 2025

The Vanguard Group, Inc.

5.12M

9.25%

-14.09K

-0.27%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.45M

6.24%

-11.08K

-0.32%

Mar 31, 2025

AllianceBernstein L.P.

2.14M

3.87%

+391.21K

+22.32%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.42M

2.56%

+429.46K

+43.56%

Mar 31, 2025

State Street Global Advisors (US)

1.19M

2.15%

-1.44K

-0.12%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.18M

2.14%

+19.63K

+1.69%

Mar 31, 2025

Loomis, Sayles & Company, L.P.

1.18M

2.14%

-25.76K

-2.13%

Mar 31, 2025

T. Rowe Price Associates, Inc.

1.01M

1.83%

+334.20K

+49.20%

Mar 31, 2025

Wellington Management Company, LLP

962.24K

1.74%

-528.72K

-35.46%

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

Global X HealthTech ETF

3.11%

SPDR S&P Health Care Equipment ETF

1.67%

Global X Robotics & Artificial Intelligence ETF

1.37%

Harbor Health Care ETF

1.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.17%

ALPS Disruptive Technologies ETF

0.95%

Langar Global HealthTech ETF

0.86%

Main Thematic Innovation ETF

0.5%

BNY Mellon Innovators ETF

0.43%

Nuveen ESG Small-Cap ETF

0.37%

Global X HealthTech ETF

占比3.11%

SPDR S&P Health Care Equipment ETF

占比1.67%

Global X Robotics & Artificial Intelligence ETF

占比1.37%

Harbor Health Care ETF

占比1.19%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比1.17%

ALPS Disruptive Technologies ETF

占比0.95%

Langar Global HealthTech ETF

占比0.86%

Main Thematic Innovation ETF

占比0.5%

BNY Mellon Innovators ETF

占比0.43%

Nuveen ESG Small-Cap ETF

占比0.37%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Procept Biorobotics Corp

58.930USD

Procept Biorobotics Corp

58.930

概览

公司

财务